Predictors of opioid use at long-term follow-up following radiation therapy for head and neck cancer
4 affiliations
- 1School of Medicine, Baylor College of Medicine, Houston, TX, United States; Corresponding author. Baylor College of Medicine, 1 Baylor Plz, Houston, TX, 77030,United States.
- 2Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- 3Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- 4Department of Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Abstract
Context: Long-term opioid use after radiation therapy remains a clinically important issue among cancer survivors and patients with chronic pain. Identifying factors associated with opioid use at long-term follow-up may help target early interventions and supportive care resources. Objective: To identify demographic, clinical, pain-related, and opioid-related factors associated with opioid use at FU2 (the second follow-up assessment occurring ≥180 days after the completion of radiation therapy). Methods: Retrospective cohort study of patients receiving radiation therapy (RT) with available pain and opioid follow-up data. Opioid use at long-term follow-up (FU2) was defined by active (scheduled or as-needed) opioid prescriptions at ≥180 days after RT. Multivariable logistic regression analyses were performed to identify predictors of opioid use at long-term follow-up (FU2). Candidate predictors included demographic variables, smoking history, opioid use before RT, baseline pain scores, longitudinal pain burden (AUC), and pain scores after RT. Results: Higher opioid use within one week before RT start was independently associated with opioid use at FU2. Weekly pain burden during RT and early post-treatment pain scores demonstrated trends toward significance. Demographic factors, including age, sex, and smoking status, were not significantly associated with opioid use at long-term follow-up (FU2). Conclusions: Pre-treatment opioid exposure was independently associated with opioid use at long-term follow-up (FU2). Prospective studies are required to determine whether pre-treatment opioid optimization improves long-term outcomes.
Related
- Acute Myocardial Infarction from Stent Thrombosis Following a Loss to Follow-up Triggered by Financial Barriers to PCSK9 Inhibitor Therapy
- Fournier's Gangrene Following Hydrogel Spacer-related Rectal Ulcer and Fistula in a Patient Undergoing Radiation Therapy for Prostate Cancer
- Radiation-induced tumor following pencil beam scanning proton therapy for pediatric intracranial ependymoma: a pragmatic analysis of risk factors
- Predictors of futile recanalization following endovascular therapy for acute anterior circulation large vessel occlusion stroke: a retrospective cohort study
- Predictors of 6-month clinical change in primary progressive aphasia following language therapy and transcranial magnetic stimulation
BibTeX
@article{shao2026predictors,
title = {{Predictors of opioid use at long-term follow-up following radiation therapy for head and neck cancer}},
author = {Katherine Qingya Shao and Guanqing Chen and Md Mahin and Amy Moreno and Clifton D. Fuller and Saba Javed},
journal = {Oral Oncology Reports},
year = {2026},
month = oct,
doi = {10.1016/j.oor.2026.100804},
url = {https://doi.org/10.1016/j.oor.2026.100804},
note = {CC BY},
}
RIS
TY - JOUR
TI - Predictors of opioid use at long-term follow-up following radiation therapy for head and neck cancer
AU - Katherine Qingya Shao
AU - Guanqing Chen
AU - Md Mahin
AU - Amy Moreno
AU - Clifton D. Fuller
AU - Saba Javed
PY - 2026
DA - 2026/10/31
JO - Oral Oncology Reports
DO - 10.1016/j.oor.2026.100804
UR - https://doi.org/10.1016/j.oor.2026.100804
AB - Context: Long-term opioid use after radiation therapy remains a clinically important issue among cancer survivors and patients with chronic pain. Identifying factors associated with opioid use at long-term follow-up may help target early interventions and supportive care resources. Objective: To identify demographic, clinical, pain-related, and opioid-related factors associated with opioid use at FU2 (the second follow-up assessment occurring ≥180 days after the completion of radiation therapy). Methods: Retrospective cohort study of patients receiving radiation therapy (RT) with available pain and opioid follow-up data. Opioid use at long-term follow-up (FU2) was defined by active (scheduled or as-needed) opioid prescriptions at ≥180 days after RT. Multivariable logistic regression analyses were performed to identify predictors of opioid use at long-term follow-up (FU2). Candidate predictors included demographic variables, smoking history, opioid use before RT, baseline pain scores, longitudinal pain burden (AUC), and pain scores after RT. Results: Higher opioid use within one week before RT start was independently associated with opioid use at FU2. Weekly pain burden during RT and early post-treatment pain scores demonstrated trends toward significance. Demographic factors, including age, sex, and smoking status, were not significantly associated with opioid use at long-term follow-up (FU2). Conclusions: Pre-treatment opioid exposure was independently associated with opioid use at long-term follow-up (FU2). Prospective studies are required to determine whether pre-treatment opioid optimization improves long-term outcomes.
SN - 2772-9060
ER -